FDA drug approvals, clinical trials, and progressive medical treatments.
Cutting-edge research uncovers distinct brain network alterations and genetic signatures in severe temporal lobe epilepsy, offering new avenues for targeted therapies.
Four researchers affiliated with MIT, including faculty Sven Dorkenwald and Whitney Henry, have been named 2026 Searle Scholars for their innovative work.
Groundbreaking research suggests CBD may slow Alzheimer's progression by modulating brain inflammation. A new study in eNeuro highlights cannabidiol's potential.
Groundbreaking research from NUS Medicine shows caffeine can specifically reverse social memory deficits caused by sleep deprivation, targeting a key brain circuit.
Scripps Research scientists have identified a molecular 'switch' in the STING protein that fuels Alzheimer's brain inflammation. Blocking it shows promise for new therapies.
Explore photobiomodulation (PBM) and its potential for brain health, neurodegenerative conditions, and caregiver support with expert insights from Neuronic.
Groundbreaking research reveals how prenatal epigenetic markers interact with infant gut microbes, influencing early brain development and potential links to autism and ADHD.
Pioneering research reveals a specific brain circuit in the amygdala linked to anxiety and social deficits. Restoring its balance reversed these behaviors in mice, offering new therapeutic avenues.
Groundbreaking research published in Molecular Neurodegeneration reveals DAPK1's role in tauopathy, linking its activity to cognitive decline and identifying a new therapeutic target.
NeuroBulletin.com reports on groundbreaking research showing that restoring cellular autophagy in retinal ganglion cells could prevent mitochondrial damage and halt glaucoma's progression.
Groundbreaking study identifies precise blood-based biomarkers for Alzheimer's, Parkinson's, Lewy body, and Frontotemporal dementias, promising earlier, less invasive diagnosis.
Major health headlines: Champion Foods' Salmonella recall, global Ebola containment, AI's medical monitoring gaps, and a lawsuit against OpenAI. NeuroBulletin.com reports.